EP3706739
Notkun á rílúsól-forlyfjum til að meðhöndla slingur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.11.2018EP published:
16.10.2024EP application number:
18876779.2
EP translation filed:
28.11.2024Grant published:
15.12.2024EPO information:
European Patent Register
Max expiry date:
10.11.2038Expiry date:
10.11.2026Next due date:
30.11.2026
Title in English:
USE OF RILUZOLE PRODRUGS TO TREAT ATAXIASLanguage of the patent:
English
Timeline
Today
11.11.2018EP application
16.10.2024EP Publication
28.11.2024Translation submitted
15.12.2024Registration published
10.11.2026Expires
Owner
Name:
Biohaven Therapeutics Ltd.Address:
215 Church Street, New Haven, CT 06510, US
Inventor
Name:
CORIC, VladimirAddress:
New Haven Connecticut 06510, US
Name:
BERMAN, RobertAddress:
New Haven Connecticut 06510, US
Name:
BEINER, MelissaAddress:
New Haven Connecticut 06510, US
Name:
L'ITALIEN, GilbertAddress:
New Haven Connecticut 06510, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762584856 PDate:
12.11.2017Country:
US
Number:
201862717948 PDate:
13.8.2018Country:
US
Classification
Categories:
A61K 31/428, A61K 31/427, A61K 31/4985, A61P 35/00, C07D 277/82, C07D 417/12, A61K 9/48, A61K 9/20, A61P 25/14
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 25.11.2024
Expires: 10.11.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.11.2025
Expires: 10.11.2026
Payer: Árnason Faktor ehf.